Ultimo aggiornamento: Agosto 25, 2026
Most men over fifty develop some degree of prostate enlargement, and many of them adjust to the symptoms so gradually that they stop noticing. The Punteggio internazionale dei sintomi della prostata (IPSS) exists to make that visible: it converts a vague sense of getting up at night and not emptying properly into a number, which is what allows a urologist to decide between watching, medicating and operating — and to tell later whether anything actually improved.
- Centro di urologia Ospedale di Bangkok Thailandia Prenotazione online 02-310-3009 bhquro@bdms.co.th
- Ospedale Samitivej Sriracha Chonburi 088-022-1445
Before the Score: What Is Not BPH
The IPSS measures symptoms, not their cause, and this is where it misleads people most often. Identical scores are produced by an enlarged prostate, an overactive bladder, a urethral stricture, poorly controlled diabetes, a neurological condition, or simply drinking a great deal in the evening. A high score does not mean your prostate is the problem, and a normal score does not mean your prostate is healthy. Notably, the IPSS says nothing whatsoever about prostate cancer — early prostate cancer usually causes no symptoms at all, so a reassuring score is not a cancer screen and should never be treated as one.
Go to an emergency department, or call 1669 in Thailand, for:
- Complete inability to pass urine with a painfully full bladder — acute retention
- Fever and chills with urinary symptoms, feeling generally unwell
And arrange assessment rather than filling in a questionnaire if you have visible blood in the urine, unexplained weight loss or new bone pain, or symptoms that appeared suddenly rather than gradually — gradual onset over years is the pattern that fits benign enlargement.

What the Seven Questions Cover
A note on why the questionnaire is not reproduced here: the IPSS is the American Urological Association Symptom Index, and it is a copyrighted instrument. Publishing the item wording on a public web page requires permission, which this site does not hold, so what follows describes what each question covers rather than reproducing it. Your doctor will give you the actual form — which is better anyway, since a previous version of this page carried a loose translation of the answer options that changed their meaning.
All seven questions ask about the last month. Six of them are answered on a frequency scale running from not at all through less than one time in five, less than half the time, about half the time e more than half the time to almost always, scored 0 to 5. The seventh, on night-time waking, is scored by the number of times, from none up to five or more — also 0 to 5.
- Incomplete emptying — how often it feels as though the bladder has not emptied fully after finishing
- Frequency — how often you have had to go again within two hours
- Intermittency — how often the stream has stopped and started
- Urgenza — how often it has been difficult to postpone going
- Flusso debole — how often the flow has been weak
- Straining — how often you have had to push or strain to begin
- Nocturia — how many times you typically get up at night to urinate
Those seven split into two groups that behave differently and respond to different treatment: voiding symptoms (weak stream, straining, intermittency, incomplete emptying), which are what an obstructing prostate produces, and storage symptoms (frequency, urgency, nocturia), which come from how the bladder has adapted. A man whose score is driven almost entirely by storage symptoms may not be helped much by treating the prostate alone — which is one reason the total on its own is a blunt instrument.
How the Score Is Banded
The seven answers add to a total from 0 to 35:
| Total score | Symptom severity |
|---|---|
| 0–7 | Mild |
| 8–19 | Moderato |
| 20–35 | Severe |
Broadly, mild symptoms are watched with lifestyle measures, moderate symptoms usually prompt a discussion about medication, and severe symptoms bring procedures into the conversation. A change of around three points is generally regarded as the smallest difference a man actually notices, which is the figure worth remembering when judging whether a treatment has worked.

The Eighth Question, Which Often Decides Everything
After the seven symptom questions comes one more, scored separately from 0 to 6, asking how you would feel about spending the rest of your life with your urinary symptoms exactly as they are now — answered on a scale from delighted through mixed to terrible.
It is deliberately not added to the total, and in practice it frequently matters more than the seven that are. Two men can both score 14. One is mildly irritated and would rather not take a tablet every day; the other has stopped travelling, stopped drinking anything after six o’clock and is exhausted from broken sleep. The symptom score cannot tell those two men apart. The quality of life question can, and it is usually what decides whether treatment is worth it — so answer it honestly rather than stoically.
One more thing worth knowing, because it surprises almost everyone: prostate size correlates poorly with symptoms. A large prostate can cause very little trouble and a modest one can cause a great deal, depending on where the tissue sits and how the bladder has responded. That is why treatment follows the score and the quality of life answer rather than a measurement on a scan. What the assessment adds alongside the questionnaire is a flow rate, a check of how much urine is left behind after voiding, a urine test, PSA where appropriate, and a review of your medications — several common drugs make these symptoms worse.
Domande frequenti
What is the International Prostate Symptom Score?
A validated seven-question instrument, also known as the AUA Symptom Index, assessing lower urinary tract symptoms over the past month: incomplete emptying, frequency, intermittency, urgency, weak stream, straining and nocturia. Each is scored 0 to 5, giving a total from 0 to 35, banded as mild, moderate or severe. A separate eighth question on quality of life is scored 0 to 6 and kept apart from the total. It is a copyrighted instrument, so the item wording is not reproduced here.
How is the IPSS interpreted?
A total of 0 to 7 is mild, 8 to 19 moderate, and 20 to 35 severe. Mild symptoms are generally watched with lifestyle measures, moderate symptoms prompt a discussion about medication, and severe symptoms bring procedures into consideration. A change of about three points is the smallest difference most men actually notice, so that is the benchmark for judging whether treatment has helped.
Does a high IPSS mean my prostate is enlarged?
Not necessarily. The same symptoms are produced by an overactive bladder, a urethral stricture, poorly controlled diabetes, neurological conditions and evening fluid habits. Prostate size also correlates poorly with symptoms: a large prostate may cause little trouble and a modest one a great deal. The score measures how much you are affected, not what is causing it, which is why assessment includes a flow rate, post-void residual, urine test and medication review.
Does the IPSS screen for prostate cancer?
No, and this is the most important misunderstanding to correct. Early prostate cancer usually causes no urinary symptoms at all, so a low IPSS provides no reassurance about cancer whatsoever. Cancer risk is assessed separately, through PSA testing and examination where appropriate, and that is a distinct conversation from symptom management.
Why is the quality of life question scored separately?
Because how much the symptoms bother you is a different question from how many symptoms you have, and it often matters more. Two men with identical totals can be affected completely differently — one mildly irritated, the other no longer travelling and chronically short of sleep. That answer usually decides whether treatment is worthwhile, so it should be answered honestly rather than stoically.
When do urinary symptoms need urgent attention?
Complete inability to pass urine with a painfully full bladder, or fever and chills with urinary symptoms, mean an emergency department or 1669 in Thailand. Visible blood in the urine, unexplained weight loss, new bone pain, or symptoms that appeared suddenly rather than gradually should be assessed rather than scored on a questionnaire.
Book an Appointment
Dr. Soarawee Weerasopone assesses and treats prostate enlargement and lower urinary tract symptoms at Ospedale Bangokok Sede Centrale and at Samitivej Sriracha Hospital, Chonburi — Urology department 088-022-1445. The questionnaire is completed in the clinic; bringing a list of your current medications helps, since several common ones worsen these symptoms. Questions about cost are answered by the hospital rather than by Dr. Soarawee — for Bangkok Hospital, by email to bhquro@bdms.co.th.
Bangkok Hospital Telemedicine is available for patients who cannot attend in person, including international patients — arrange it in advance by email to the Urology department at bhquro@bdms.co.th. It suits reviewing symptoms and results you already have; flow rate, ultrasound and examination require an in-person visit. Samitivej Sriracha is in-person only.
Disclaimer: This article is written and reviewed by Dr. Soarawee Weerasopone, a board-certified urologist at Bangkok Hospital Headquarters. It is educational only, is not medical advice, and does not create a doctor–patient relationship. The IPSS grades symptom severity; it does not identify a cause and does not screen for prostate cancer. It is a copyrighted instrument and its item wording is not reproduced here. No diagnosis, prescription or individual medical advice is given through personal messaging channels or social media, and Dr. Soarawee operates no public social media account — any account offering private consultation in his name is fraudulent. Inability to pass urine, or fever with urinary symptoms, means an emergency department or 1669 in Thailand.
Scritto e revisionato dal punto di vista medico da: Dott. Soarawee Weerasopone (Dott. Pom) — Urologo certificato, Sede centrale dell'Ospedale di Bangkok, in attività dal 2016. Fellowship: Chirurgia robotica, Chang Gung Memorial Hospital, Taiwan (2019) · Periodo di osservazione: Endourologia, Juntendo University Hospital, Tokyo (2022) · Ricercatore e osservatore clinico, Scott Department of Urology, Baylor College of Medicine, USA (2025–2026).

Dr. Soarawee Weerasopone (Dr. Pom) is a board-certified urologist at Bangkok Hospital Headquarters, specializing in Men’s Health, Robotic Surgery (da Vinci Xi) and Kidney Stone treatment. He is currently a Research Scholar and Clinical Observer at the Scott Department of Urology, Baylor College of Medicine (2025–2026), under Prof. Mohit Khera. He completed a Robotic Surgery Fellowship at Chang Gung Memorial Hospital, Taiwan (2019) and an Endourology Observership at Juntendo University Hospital, Tokyo (2022).

